SA

Shivam Agarwal

Active Director Director DIN 09332439
DIN 09332439 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Shivam Agarwal

Data last updated:

Shivam Agarwal is a Director at Upraj Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Upraj Pharmaceuticals Private Limited reported revenue of ₹32.4 Lakh (FY 2025).

DIN 09332439
Primary Designation Director
Industry Chemicals
First Appointment 27 Sep 2021
Oldest Company Age 31 yrs
Largest company Upraj Pharmaceuticals Private Limited · ₹32.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Sep 20211995₹32.4 Lakh (FY 2025)Active

Board colleagues of Shivam Agarwal

Directorship timeline

Open interactive timeline →
Upraj Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shivam Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivam Agarwal

Shivam Agarwal currently holds 1 directorship: Upraj Pharmaceuticals Private Limited (Director, since 27 Sep 2021, revenue ₹32.4 Lakh (FY 2025)).

Shivam Agarwal was first appointed on 27 Sep 2021 as Director at Upraj Pharmaceuticals Private Limited.

The current boards of Shivam Agarwal's companies include Bal Kishan Agarwal (Upraj Pharmaceuticals Private Limited), Vinita Rani (Upraj Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available